HFA Cardio Talk
The HFA Cardio Talk podcast offers updates on heart failure topics through monthly episodes featuring conversations between junior HF specialists and internationally renowned experts. Each episode lasts approximately 15 minutes and covers diverse subjects related to heart failure. The podcast is produced by the European Society of Cardiology and is part of a series of ESC podcasts including ESC Cardio Talk and EHRA Cardio Talk.
Episodes
Cardiogenic shock - when to consider MCS
With Cornelia Margineanu, University of Medicine and Pharmacy Carol Davila, Bucharest - Romania and Holger Thiele, Heart Center Leipzig at University of Leipzig, Leipzig - Germany. In this episode, Cornelia Margineanu interviews Holger Thiele on the practical approach to temporary mechanical circulatory support in heart failure. Specific examples and clinical scenarios in which temporary mechanica
AI4HF discussions on patient perspectives and trust in AI for healthcare (part 2)
With Gregorio Sambataro and two patients: Caius and Ulrich. Gregorio Sambataro of the European Heart Network chats with Caius and Ulrich about their personal experiences with heart disease and their thoughts on the expanding use of artificial intelligence in healthcare. The conversation delves into important themes such as trust in technology and patients' responsibility to actively participate in
AI4HF discussions on patient perspectives and trust in AI for healthcare (part 1)
With Mehitabel Holler and two patients: Sheilagh and Karen. In this episode, Mehitabel talks with Sheilagh and Karen about their experiences as patients helping to build artificial intelligence tools for heart failure. The discussion touches upon first assumptions and worries about AI (trust, transparency) and the possibility of losing the human element in care. The episode also discusses the need
Late-breaking clinical science from Heart Failure Congress 2026
With Novi Yanti Sari, Siloam Hospitals Group, Jakarta - Indonesia, Sotiria Liori, National & Kapodistrian University of Athens Medical School, Athens - Greece, Sarah Birkhoelzer, University Dorset Hospital, Bournemouth - UK, Joseph Selvanayagam, Flinders University, Adelaide - Australia, Sam Straw, University of Leeds, Leeds - UK, Ida Arentz Taraldsen, Copenhagen University Hospital, Copenhagen -
Cardio-Oncology and Heart Failure
With Novi Yanti Sari, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia and Michelle Bloom, NYU Langone Health, New York, USA. In this episode Novi Yanti Sari speaks with Michelle Bloom about the intersection between cardio-oncology and heart failure. As cancer survival continues to improve, cardiovascular complications especially heart failure related to cancer therapies are increasingly
Valvular heart disease: a new chapter in heart failure management
With Giulia Bruno, Hospital Limerick, Limerick - Ireland and Piotr Ponikowski, Wroclaw Medical University, Wroclaw - Poland. In this episode, Giulia Bruno is joined by Piotr Ponikowski to explore the complex interplay between valvular heart disease and heart failure. As our understanding of secondary mitral and tricuspid regurgitation evolves, new questions are emerging around prognosis, optimal t
Post myocardial infarction – how to prevent, diagnose, and treat heart failure
With Liemena Harold Adrian, Syarifah Ambami Rato Ebu General Academic Hospital, Surabaya - Indonesia and Shelley Zieroth, St. Boniface Hospital, Winnipeg - Canada. In this episode, Liemena Harold Adrian and Shelley Zieroth discuss heart failure in post–myocardial infarction patients, covering how myocardial infarction leads to the development of heart failure despite advances in reperfusion and a
The evolving landscape in the treatment of amyloidosis
With Felix Lindberg, Karolinska Institutet & Södersjukhuset Hospital, Stockholm – Sweden and Marianna Fontana, National Amyloidosis Center, University College London, London – UK. In this episode, Felix Lindberg and Marianna Fontana discuss the evolving landscape in the treatment of cardiac amyloidosis. After exploring the pathophysiology of cardiac AL and ATTR amyloidosis and recent years' insigh
Conduction system pacing: the right choice in heart failure?
With Maria Tereza Sampaio de Sousa Lira, Federal University of Pernambuco - Brazil and Anja Zupan Meznar, University Medical Centre Ljubljana - Slovenia. This episode will discuss when conduction system pacing (CSP) may be the appropriate pacing strategy for heart failure patients, particularly those with pacing-induced dyssynchrony or suspected pacing-induced cardiomyopathy (PICM). Key talking po
A multidisciplinary team approach to HF
With Felix Lindberg, Karolinska Institute & Karolinska University Hospital, Stockholm - Sweden, Martha Kyriakou, European University of Cyprus, Nicosia - Cyprus and Maggie Simpson, University of Edinburgh, Edinburgh - UK. In this episode, Felix Lindberg, Martha Kyriakou, and Maggie Simpson discuss multidisciplinary care in heart failure, exploring why HF complexity and multimorbidity make coordina
Heart failure in adult congenital heart disease patients
With Sotiria Liori, Attikon University Hospital, National and Kapodistrian University of Athens - Greece and Julie De Backer, Ghent University Hospital - Belgium. In this episode, Sotiria Liori and Julie De Backer discuss heart failure in adult congenital heart disease patients — covering how congenital lesions and prior repairs shape epidemiology and mechanisms (ventricular remodeling, valvular a
Inotropes and vasodilators in heart failure
With Tim Balthazar, University Hospital of Brussels - Belgium and Luca Fazzini, Papa Giovanni XXIII Hospital, Bergamo - Italy. In this episode of HFA CardioTalk, Luca Fazzini interviews Tim Balthazar on the contemporary use of vasodilators and inotropic agents in heart failure. The conversation explores the gaps in current guidelines, the hemodynamic profile of patients suited for vasodilator ther
The future of trials in heart failure
With Gregorio Tersalvi, Mayo Clinic, Rochester - USA, and Faiez Zannad, University of Lorraine, Nancy - France. In this episode of HFA CardioTalk, Gregorio Tersalvi interviews Faiez Zannad on the future of trials in heart failure. Together, they explore how the landscape of heart failure trials has evolved, the major challenges in trial design today, the relevance of current and emerging outcom
Late-breaking clinical science from ESC Congress 2025
In this episode, we give a wrap-up of late-breaking clinical science presented at the ESC Congress 2025 in Madrid. First, David Berg presents the DAPA ACT HF-TIMI 68 trial, reporting on dapagliflozin in patients hospitalized for acute heart failure, along with a meta-analysis of SGLT2 inhibitors in this setting. Next, Javed Butler highlights results of the VICTOR trial, a large phase 3 study of ve
Iron in heart failure - case closed?
Wtih Robert Mentz, Duke University, North Carolina - USA, and Cornelia Margineanu University of Medicine and Pharmacy Carol Davila, Bucharest - Romania. A focused discussion and an update on the latest developments in iron deficiency — a journey from definition to outcomes through available therapeutic options. Not to be missed! This 2025 HFA Cardio Talk podcast series is supported by Bayer AG in
Late Breaking Clinical Trial updates from Heart Failure 2025
With Kevin Damman, University Medical Center Groningen, Groningen - The Netherlands, Floran Sahiti, University Hospital of Wurzburg, Wurzburg - Germany, Joao Pedro Ferreira, University of Porto, Porto - Portugal, Novi Yanti Sari, Siloam Hospitals Group, Jakarta - Indonesia, Marat Fudim, Duke University Medical Center, Durham, NC - USA, Gregorio Tersalvi, Mayo Clinic, Rochester, MN - USA, Jose Luis
Management of LVAD in patients with advanced heart failure
With Justyna Sokolska, Institute of Heart Diseases, Wroclaw Medical University, Wroclaw - Poland, and Maja Cikes, University of Zagreb School of Medicine, Head at the Unit for Heart Failure and Mechanical Circulatory Support, Department of Cardiovascular Diseases, University Hospital Center, Zagreb - Croatia. In this episode of HFA CardioTalk, Justyna Sokolska interviews Maja Cikes on the challeng
Inequalities in heart failure: sex, socioeconomic status, and ethnicity
With Robert M.A. van der Boon, Erasmus Medical Center, Rotterdam - The Netherlands, and Anuradha Lala, Mount Sinai Fuster Heart Hospital, New York City - USA. In this episode of HFA Cardio talk, we dive into how factors like sex, socio-economics status and ethnicity shape the way heart failure presents and progresses in different populations. We'll discuss why recognizing these differences is crit
Rapid up-titration of GDMT in heart failure
With Henrique Arfsten, Medical University of Vienna, Vienna - Austria and Alexandre Mebazza, Hospital Lariboisiere, Paris - France. In this episode of HFA CardioTalk, Henrike Arfsten and Alexandre Mebazaa discuss the importance of rapid initiation and titration of guideline-directed medical heart failure therapy. A focus will be on data from the STRONG-HF trial, which demonstrated safety and eff
Obesity in Heart Failure
With Novi Yanti Sari, Siloam Hospitals, Jakarta - Indonesia, and Mark Petrie, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow - UK. In this episode of the HFA podcast series, we explore the complex relationship between obesity and heart failure, discussing challenges, management strategies, and the latest therapies, while emphasising the importance of integrated ca
Invasive Monitoring in Heart Failure
With Jasper Brugts, Erasmus Medical Center Rotterdam, Rotterdam - The Netherlands and Floran Sahiti, University Hospital Würzburg and Comprehensive Heart Failure Center Würzburg, Würzburg - Germany. In this episode of the HFA Podcast Series, we will discuss telemonitoring in general, with a main focus on invasive monitoring in heart failure, the current evidence, and the advantages and disadvantag
Understanding revascularization in heart failure: why, for whom, and when
With Daniella Motta da Costa Dan, University of São Paulo - Brazil, and Marianna Adamo, University of Brescia - Italy. In this episode of HFA CardioTalk, Daniella Motta interviews Marianna Adamo on the controversies, consensus, and challenges surrounding revascularization in ischemic heart failure. The discussion highlights major clinical trials, emphasizes the importance of selecting appropriate
Heart Failure in Pregnancy: Peripartum Cardiomyopathy
With Emmanouil Kampanieris, University General Hospital of Heraklion, Heraklion - Greece, and Peter Van Der Meer, University Medical Centre Groningen, Groningen - The Netherlands. In this episode, Peter Van Der Meer and Emmanouil Kampanieris discuss peripartum cardiomyopathy, a potentially life-threatening condition that presents as heart failure with reduced ejection fraction in women in the last
Controversies in ICD/CRT implantation in non-ischemic cardiomyopathy for primary prevention
With Nicolas Verheyen, Medical University of Graz, Graz - Austria, and Lars Kober, Rigshospitalet, Copenhagen University Hospital, Copenhagen - Denmark. In this episode of HFA CardioTalk, Nicolas Verheyen interviews Lars Kober on controversies in ICD/CRT implantation in non-ischemic cardiomyopathy for primary prevention. They focus in particular on the importance of selecting the right patients,
Heart Failure clinical trials from ESC Congress 2024
With Jozine ter Maaten, University Medical Center Groningen - The Netherlands, Antonio Cannata, King's College London - UK, Mateusz Sokolski, Wroclaw Medical University - Poland, Henrike Arfsten, Medical University of Vienna - Austria, Stefan Anker, Charité University Hospital Berlin - Germany, Muthiuh Vaduganathan, Brigham and Women's hospital, Harvard Medical School Boston - USA, Cornelia Margin
Worsening Heart Failure: Definition, Management, and Outcomes
With Guillaume Baudry, University Hospital of Brabois, Nancy - France, and Marco Metra, University of Brescia - Italy. In this episode of the HFA Cardiotalk podcast, Guillaume Baudry interviews Marco Metra, the lead author of the recent HFA clinical consensus statement on worsening heart failure. They delve into the definition of worsening heart failure, its prognosis, prevention strategies, and b
Natriuresis-Guided Diuresis in Acute Heart Failure
With Raja Ezman Faridz Bin Raja Shariff, Universiti Teknologi MARA, Selangor - Malaysia, and Kevin Damman, University Medical Centre Groningen - The Netherlands In this episode of the HFA Cardiotalk podcast, Ezman Shariff interviewed Kevin Damman – a key opinion leader in the field of cardiorenal interactions, to better understand the role natriuresis plays in the acute heart failure and what we
Late Breaking Clinical Trial updates from Heart Failure 2024
With Jozine ter Maaten, University Medical Center Groningen, Groningen - the Netherlands, Marta Cobo Marcos, Hospital Puerta de Hierro, Madrid - Spain, Mateusz Sokolski, Wroclaw Medical University, Wroclaw, Poland, Aferdita Spahillari, Duke University Hospital, Durham, NC - USA, Laura Cohen, Massachusets General Hospital, Boston, MA - USA, Antonio Cannata, King's College London, London - United Ki
Atrial Fibrillation ablation in Heart Failure patients
With Jozine M. ter Maaten, University Medical Centre Groningen, Groningen - Netherlands, Bart A. Mulder, 2022-2024, University Medical Centre Groningen, Groningen - Netherlands & Giuseppe Boriani, Polyclinic Modena University Hospital, Modena -Italy. Atrial fibrillation and heart failure often co-exist and influence each other. Treatment of AF specifically in the setting of heart failure can be ch
Future Pathways: Guiding the next generation of heart failure specialists
With Cornelia Margineanu, Bucharest - Romania & Thomas Felix Luscher, London - UK A brief description of the discussion, which I have provided below: "In this episode, Dr. Cornelia Margineanu interviews Professor Thomas F. Lüscher on Education and professional development of the future generation of heart failure specialists, covering the entire pathway for young physicians, from training and havi
Reversible causes of Heart Failure
With Mateusz Sokolski, Wroclaw Medical University, Wroclaw - Poland & Amina Rakisheva, Scientific Research Institute of Cardiology and Internal Diseases, Almaty - Kazakhstan. Might heart failure be reversible or does it go only into remission in some cases? During this podcast, we discuss these issues, exploring the possibility of reversing heart failure and ending with regenerative medicine. "Thi
New perspectives in HF treatment
With Alberto Esteban-Fernández. Severo Ochoa University Hospital, Madrid - Spain & John McMurray. BHF Glasgow Cardiovascular Research Centre, Glasgow - UK. We discuss the implementation of 2021 HF guidelines, the possibility of implementing foundational therapy in clinical practice, and difficulties and barriers. Also, we discuss future heart failure treatments in the coming years. Access the 202
The role of Artificial intelligence in heart failure.
With Antonio Cannata, King's College London - UK and Folkert Asselbergs, Amsterdam University Medical Centre - Netherlands. In this episode of HFA CardioTalk Antonio Cannata interviews one of the pioneer in digital medicine and artificial intelligence in cardiovascular medicine, Prof Folkert Asselbergs. Several interesting insights were discussed on the present role of AI in Heart Failure and what
The Role of Circulating Biomarkers in Heart Failure
With Henrike Arfsten,Medical University of Vienna - Austria & Antoni Bayes-Genis, Heart Institute, University Hospital Germans Trias and Pujol de Badalona - Spain In this episode of HFA CardioTalk, Henrike Arfsten interviews Antoni Bayes-Genis on circulating biomarkers in heart failure. They focus in particular on natriuretic peptides and discuss the benefits of biomarkers assessment and their fun
Clinical inertia and optimization of heart failure therapy
With Chris Kapelios, Onassis Cardiac Surgery Center, Athens - Greece & Gianluigi Savarese, Karolinska University Hospital, Stockholm - Sweden. This HFA CardioTalk podcast episode addresses Clinical inertia and optimization of heart failure therapy. The data we have on use of HF medications come from registries and may not be generalizable to unselected, real-world populations. The proportion of HF
Making sense of clinical trials. A conversation with Stuart Pocock.
With Antonio Cannata, King's College London, London - UK & Stuart Pocock, London School of Hygiene & Tropical Medicine, London - UK. In this episode of HFA CardioTalk, Antonio Cannata interviews Stuart Pocock on how to understand randomised clinical trials. From the use of observational data to the key points in critically interpreting the results. Don't forget: a p value is no substitute for a br
Heart failure insights from the ESC congress 2023, Amsterdam, the Netherlands
With Henrike Arfsten, University of Vienna, Vienna - Austria, Juan Pablo Kaski, University College London, London - United Kingdom, Mateusz Sokolski, Wroclaw Medical University, Wroclaw - Poland, Jozine ter Maaten, University Medical Center Groningen, Groningen - the Netherlands, Peter van der Meer, University Medical Center Groningen, Groningen - the Netherlands, Antonio Cannata, King's College L
Cardiorenal axis and congestion
With Wilfred Mullens, Hospital Oost-Limburg (ZOL) and Hasselt University - Belgium & Alberto Esteban-Fernández, Hospital Universitario Severo Ochoa y Alfonso X El Sabio University - Spain. This podcast addresses some of the main developments in congestion management in heart failure patients, especially those with cardiorenal syndrome. We discuss the ADVOR and CLOROTIC trials and their implicati
Preventing Heart Failure From Evidence to Action
With Amitai Segev, Sheba Medical Center, Ramat Gan - Israel and Massimo Francesco Piepoli, IRCCS San Donato Polyclinic, San Donato Milanese - Italy In this episode of HFA Cardio Talk, we dive into the world of heart failure prevention with our esteemed guest, Prof. Massimo Piepoli, an eminent figure in preventive cardiology, as he is interviewed by Dr. Amitai Segev. Join us as we discuss the impo
Exploring the journey of Heart Transplantation - where are we in 2023?
With Interviewee: Doctor Tuvia Ben Gal, Rabin Medical Center, Petah Tikva, Israel and Interviewer: Doctor Cornelia Margineanu, Emergency Institute of Cardiovascular Diseases Prof. Dr. C.C. Iliescu, Bucharest, Romania. In this podcast, Dr Cornelia Margineanu from Bucharest, Romania interviews professor Tuvia Ben Gal from Petah Tikva, Israel on cardiac transplantation. Throughout the podcast, the ex
Insights from late breaking clinical trials from the Heart Failure Congress 2023, Prague, Czech
Interviewees: Associate Professor Jasper Brugts, Erasmus University Medical Centre of Rotterdam, The Netherlands; Professor John Cleland and Doctor Ross Campbell, University of Glasgow, United Kingdom of Great Britain & Northern Ireland; Doctor Jeroen Dauw AZ Saint-Lucas, Ghent, Belgium and Interviewers: Doctor Antonio Cannata, King's College London, United Kingdom of Great Britain & Northern Irel
A deep dive into translational science in Heart Failure. Lessons learnt and future perspectives.
With Antonio Cannata, BHF Centre of Excellence, School of Cardiovascular and Metabolic Medicine and Science. Faculty of Life Science and Medicine, King's College London, London - UK & Mauro Giacca, King's College, BHF Centre of Excellence, School of Cardiovascular and Metabolic Medicine and Science. Faculty of Life Science and Medicine, King's College London, London - UK. In this episode, Dr Canna
Shock Talk: Epidemiology, pathophysiology and contemporary management of cardiogenic shock
With Sotiria Liori, Attikon University Hospital, Athens - Greece and Ovidiu Chioncel, Emergency Institute for Cardiovascular Disease - Institut De Boli Cardiovasculare C.C.Iliescu, Bucharest; University of Medicine Carol Davila, Bucharest - Romania. In the latest episode of HFA Cardio Talk, Dr. Sotiria Liori, member of the HFA Young Committee, interviews Prof. Ovidiu Chioncel on cardiogenic shock.
Advanced heart failure: definition, diagnostic work-up, tips and tricks - introduction to the first HFA Advanced Heart Failure course
With Dr. Mateusz Sokolski, Wroclaw Medical University – Poland and Prof. Finn Gustafsson, University of Copenhagen, Copenhagen - Denmark In February´s HFA Cardio Talk, Finn Gustafsson, Professor of Cardiology at the University of Copenhagen, director of the advanced heart failure, transplantation and mechanical circulatory support program at Rigshospitalet in Copenhagen, Denmark and member of the
Diagnosis and management of myocarditis: current state and future perspectives
With Doctor Emanuele Bobbio, Sahlgrenska University Hospital, Gothenburg - Sweden and Professor Carsten Tschoepe, Head of the Cardiomyopathy Unit – Campus Virchow German Heart Center at Charite (DZHK), Berlin - Germany and Head of the Cardiovascular Unit Immunocardiology, Berlin Institute of Health (BIH) at Charite - Germany In January's HFA Cardio Talk, Prof. Tschöpe, chair of the HFA Committee
Emerging key role of Patients Profiling in Heart Failure patients' management
With Brenda Moura, Military Hospital, Porto, and Faculty of Medicine of University of Porto - Portugal & Francesca Musella, Santa Maria della Grazie Hospital, Naples, Italy, Karolinska Institutet - Sweden In December´s HFA Cardio Talk, Dr. Francesca Musella interviews Dr. Brenda Moura on the emerging role of Patients´profiling in Heart Failure. The podcast starts with an overview of this emerging
Valvular heart disease in patients with heart failure
With Daniela Tomasoni and Marianna Adamo, University of Brescia, Brescia - Italy. In November's HFA Cardio Talk, Dr. Daniela Tomasoni interviews Dr.Marianna Adamo on valvular heart disease in heart failure. The podcast starts with an epidemiological overview and then addresses the main pathophysiological mechanisms of valvular heart disease in patients with heart failure. It also discusses current
The changing role of Cardiovascular Magnetic Resonance in Heart Failure patients
With Chiara Bucciarelli-Ducci (Interwiee), Royal Brompton and Harefield Hospitals, London - United Kingdom & Jessica Artico (Interwier), University College of London and Barts Heart Centre, London - United Kingdom. In this podcast, Prof Chiara Bucciarelli-Ducci, interviewed by Dr Jessica Artico, will discuss the enhanced role of Cardiovascular Magnetic Resonance in Heart Failure Patients and in th
Lived Experiences of Dyads with a Left Ventricular Assist Device: Lessons Learned for Around the World
With Angela Massouh (Host), American University of Beirut - Lebanon and Loreena Hill (Interviewee), School of Nursing and Midwifery, Queen's University Belfast - United Kingdom In September's HFA cardio podcast Dr. Angela Massouh interviews Dr. Loreena Hill on living with a Left Ventricular Assist Device, lessons learned from around the globe. This podcast will address the lived experiences of pat
Gene Editing: Paving the way to end the burden of inherited cardiomyopathies or just a useful research tool?
With Emma Louise Robinson (Host), University of Colorado, Aurora, USA. - USA and Luisa Mestroni (Interviewee), University of Colorado, Aurora, USA. In July's HFA Cardio Talk podcast, Dr Emma Robinson interviews Prof Luisa Mestroni, Director of the International Familial Cardiomyopathy Registry and Co-Director of the Molecular Genetics Program of the Cardiovascular Institute in Denver. This podcast
HFpEF – The enigma of Heart Failure
With Prof. Markus Wallner, Medical University of Graz, Graz - Austria & Rudolf de Boer, University Medical Center Groningen - Netherlands. This podcast will discuss the most recent developments in heart failure with preserved ejection fraction (HFpEF). Prof. de Boer, HFA board member and HFpEF expert, is interviewed by Dr. Wallner, chair of the HoT Committee, and will walk us through the diagnosti
Highlights from Heart Failure Congress 2022, Madrid, Spain
With Antonio Cannata, King's College London, London - UK, Mateusz Sokolski, Wrocław Medical University, Wrocław - Poland, Otilia Țica, Emergency County Hospital of Oradea, Oradea - Romania, Finn Gustafsson, University of Copenhagen - Danemark, John Cleland, Imperial College of London - UK, Theresa McDonagh, King's College London - UK, Gianluigi Savarese, Karolinska Institute - Sweden, Carolyn Sp
Tips and tricks in interpretation of clinical trials
With Petar M. Seferović, Belgrade University, Faculty of Medicine, Belgrade - Serbia & Ivan Milinković, Clinical center of Serbia, Belgrade - Serbia. The podcast discusses how major clinical trials changed the perspective on how randomized clinical trials are designed, conducted and interpreted. It gives the insight into major positive and negative aspects of the clinical trials, which results inf
Implementing the use of HF treatments in clinical practice
With Gianluigi Savaresse, Karolinska Institute, Stockholm - Sweden & Otilia Țica, University of Medicine of Oradea-Faculty of Medicine and Pharmacy of Oradea, Oradea - Romania.
The SGLT2-inhibitors revolution in Heart Failure. Current indications and future perspectives
With Giuseppe Rosano - St George's Hospital Medical School – London - UK & Antonio Cannata - King's College London, London - UK This podcast will discuss the most recent and serendipitous revolution in the field of Heart Failure, the SGLT2-inhibitors, their indications and future perspectives. Prof Rosano, interviewed by Dr Cannata, will drive through the most recent evidence supporting the use of
Medical treatment for heart failure. News and controversies from 2021 ESC heart failure Guidelines
With Ewa A. Jankowska & Mateusz Sokolski, Institute of Heart Diseases, Wroclaw Medical University, University Hospital, Wroclaw - Poland Link to paper
Recommended
Better ROI from Software Development
The Stocks and Savings Podcast
Out of Frame
Wooden Overcoats
Coffee Break Japanese
World Questions
The Physics Teaching Podcast
Preach The Word - David Legge
The Profitable Baker Podcast
The Non-Billable Podcast
CEO Stories: Conversations with Greater Birmingham business leaders
InsideAIR
